Fig. 6From: Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive careMinor variant frequencies at specified amino acid positions involved in binding the monoclonal antibodies that form ZMab in EBOV GP for the different time points post infection, including recrudescenceBack to article page